Search - tctmd.com

Displaying 141 - 160 of 3520

Sort: Relevancy | Date

Presentation TCT 2025

TCT 99: Comparative Analysis of CHA2DS2VASc, CHA2DS2VAScHSF and Mehran Risk Score for Predicting Contrast Induced Acute Kidney Injury in Stable Patients after Percutaneous Coronary Intervention

Presenter: Sami Ullah

October 27, 2025

Presentation TCT 2025

TCT 98: Elevated Calcium-Phosphate Product (CPP) is Independently Associated With Higher Cardiovascular Procedure Rates and Adverse Outcomes in Chronic Kidney Disease (CKD): A Propensity Score–Matched Analysis

Presenter: Muhammad Raffey Shabbir

October 27, 2025

Presentation TCT 2025

TCT 944: Accuracy of Artificial Intelligence Driven Prediction of Target Vessel Failure Post-PCI: A Systematic Review and Meta-Analysis

Presenter: Rahul Ravindra

October 27, 2025

Presentation TCT 2025

TCT 1003: Clinical Effectiveness of Glucagon-like peptide-1 receptor agonists on Cardiovascular outcomes Post-PCI in Type 2 Diabetes patients: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 27, 2025

Presentation TCT 2025

Blueprint for the Future of PCI with Next Generation Resorbable Technologies

Presenter: Richard J. Rapoza

October 27, 2025

Presentation TCT 2025

TCT 943: Predictors of adverse events in Patients with Premature Coronary Artery Disease undergoing PCI

Presenter: Gaurav Kumar Arora

October 27, 2025

Presentation TCT 2025

TCT 100: Patented Automated Device for Removal of Contrast From Coronary Sinus for the Prevention of Contrast Induced Nephropathy During Coronary Angiography or Intervention

Presenter: Mohammad Reza Movahed

October 27, 2025

Presentation TCT 2025

TCT 1004: Cardiovascular Outcomes of PCSK9 Inhibitor Use in Percutaneous Coronary Intervention

Presenter: Grant William Reed

October 27, 2025

Presentation TCT 2025

TCT 940: Prognostic Role of Alpha Defensin in Predicting Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention

Presenter: Rami Abu Fanne

October 27, 2025

Presentation TCT 2025

TCT 101: Percutaneous Coronary Intervention Outcomes in African American versus Non-African American Patients on Hemodialysis: Insights from a Large Single-Center PCI Registry

Presenter: Vaishnavi Sirekulam

October 27, 2025

Presentation TCT 2025

TCT 1002: Impact of Antithrombotic Therapy Modification: Post Hoc Analysis of the EPIC CAD Trial

Presenter: Seong-Bong Wee

October 27, 2025

Presentation TCT 2025

Putting CT-Guided PCI into Practice

Presenter: Yader Sandoval

October 27, 2025

Presentation TCT 2025

The Current State of CT-Guided PCI

Presenter: Evan Shlofmitz

October 27, 2025

Presentation TCT 2025

TCT 995: Less Is More? P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy following PCI In Acute Coronary Syndrome: A Meta-Analysis of Reconstructed Time-to-Event Data

Presenter: Paulo Roberto Tartuce Filho

October 27, 2025

Presentation TCT 2025

Why CT-Guided PCI Matters

Presenter: Carlos Collet

October 27, 2025

Presentation TCT 2025

TCT 998: Dual Antiplatelet Therapy (DAT) versus Triple Therapy (TAT) post Percutaneous Coronary Intervention (PCI) in patients requiring Chronic Anticoagulation: Meta-analysis.

Presenter: Kanishk Aggarwal

October 27, 2025

Presentation TCT 2025

TCT 999: One- versus three-month DAPT in patients at high or very high bleeding risk undergoing PCI: Results from the XIENCE Short DAPT Program

Presenter: Davide Cao

October 27, 2025

Presentation TCT 2025

TCT 996: One-versus three-month DAPT in High Bleeding Risk Patients With or Without Baseline Anemia Undergoing PCI

Presenter: Francesca Maria Di Muro

October 27, 2025

Presentation TCT 2025

TCT 997: Long-Term Clopidogrel vs Aspirin Monotherapy in coronary artery disease patients with High Ischemic Risk: HOST-EXAM Extended Study Post Hoc Analysis

Presenter: Jin-Eun Song

October 27, 2025

Presentation TCT 2025

TCT 437: Impact of Quantom Iterative Reconstruction on Coronary Stent Assessment in Ultra-High Resolution Photon-Counting CT: A Phantom Study

Presenter: Søren Thorup Scheuer

October 27, 2025

Advertisement

TCT 99: Comparative Analysis of CHA2DS2VASc, CHA2DS2VAScHSF and Mehran Risk Score for Predicting Contrast Induced Acute Kidney Injury in Stable Patients after Percutaneous Coronary Intervention

TCT 98: Elevated Calcium-Phosphate Product (CPP) is Independently Associated With Higher Cardiovascular Procedure Rates and Adverse Outcomes in Chronic Kidney Disease (CKD): A Propensity Score–Matched Analysis

TCT 944: Accuracy of Artificial Intelligence Driven Prediction of Target Vessel Failure Post-PCI: A Systematic Review and Meta-Analysis

TCT 1003: Clinical Effectiveness of Glucagon-like peptide-1 receptor agonists on Cardiovascular outcomes Post-PCI in Type 2 Diabetes patients: Findings from the TriNetX Database

Blueprint for the Future of PCI with Next Generation Resorbable Technologies

TCT 943: Predictors of adverse events in Patients with Premature Coronary Artery Disease undergoing PCI

TCT 100: Patented Automated Device for Removal of Contrast From Coronary Sinus for the Prevention of Contrast Induced Nephropathy During Coronary Angiography or Intervention

TCT 1004: Cardiovascular Outcomes of PCSK9 Inhibitor Use in Percutaneous Coronary Intervention

TCT 940: Prognostic Role of Alpha Defensin in Predicting Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention

TCT 101: Percutaneous Coronary Intervention Outcomes in African American versus Non-African American Patients on Hemodialysis: Insights from a Large Single-Center PCI Registry

TCT 1002: Impact of Antithrombotic Therapy Modification: Post Hoc Analysis of the EPIC CAD Trial

Putting CT-Guided PCI into Practice

The Current State of CT-Guided PCI

TCT 995: Less Is More? P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy following PCI In Acute Coronary Syndrome: A Meta-Analysis of Reconstructed Time-to-Event Data

Why CT-Guided PCI Matters

TCT 998: Dual Antiplatelet Therapy (DAT) versus Triple Therapy (TAT) post Percutaneous Coronary Intervention (PCI) in patients requiring Chronic Anticoagulation: Meta-analysis.

TCT 999: One- versus three-month DAPT in patients at high or very high bleeding risk undergoing PCI: Results from the XIENCE Short DAPT Program

TCT 996: One-versus three-month DAPT in High Bleeding Risk Patients With or Without Baseline Anemia Undergoing PCI

TCT 997: Long-Term Clopidogrel vs Aspirin Monotherapy in coronary artery disease patients with High Ischemic Risk: HOST-EXAM Extended Study Post Hoc Analysis

TCT 437: Impact of Quantom Iterative Reconstruction on Coronary Stent Assessment in Ultra-High Resolution Photon-Counting CT: A Phantom Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content